UniProt ID | RIPK3_HUMAN | |
---|---|---|
UniProt AC | Q9Y572 | |
Protein Name | Receptor-interacting serine/threonine-protein kinase 3 | |
Gene Name | RIPK3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 518 | |
Subcellular Localization | Cytoplasm, cytosol . Cell membrane. Mitochondrion . | |
Protein Description | Essential for necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members. Upon induction of necrosis, RIPK3 interacts with, and phosphorylates RIPK1 and MLKL to form a necrosis-inducing complex. RIPK3 binds to and enhances the activity of three metabolic enzymes: GLUL, GLUD1, and PYGL. These metabolic enzymes may eventually stimulate the tricarboxylic acid cycle and oxidative phosphorylation, which could result in enhanced ROS production.. | |
Protein Sequence | MSCVKLWPSGAPAPLVSIEELENQELVGKGGFGTVFRAQHRKWGYDVAVKIVNSKAISREVKAMASLDNEFVLRLEGVIEKVNWDQDPKPALVTKFMENGSLSGLLQSQCPRPWPLLCRLLKEVVLGMFYLHDQNPVLLHRDLKPSNVLLDPELHVKLADFGLSTFQGGSQSGTGSGEPGGTLGYLAPELFVNVNRKASTASDVYSFGILMWAVLAGREVELPTEPSLVYEAVCNRQNRPSLAELPQAGPETPGLEGLKELMQLCWSSEPKDRPSFQECLPKTDEVFQMVENNMNAAVSTVKDFLSQLRSSNRRFSIPESGQGGTEMDGFRRTIENQHSRNDVMVSEWLNKLNLEEPPSSVPKKCPSLTKRSRAQEEQVPQAWTAGTSSDSMAQPPQTPETSTFRNQMPSPTSTGTPSPGPRGNQGAERQGMNWSCRTPEPNPVTGRPLVNIYNCSGVQVGDNNYLTMQQTTALPTWGLAPSGKGRGLQHPPPVGSQEGPKDPEAWSRPQGWYNHSGK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSCVKLWPS ------CCCEEECCC | 27.84 | - | |
5 | Ubiquitination | ---MSCVKLWPSGAP ---CCCEEECCCCCC | 49.51 | 29967540 | |
55 | Ubiquitination | AVKIVNSKAISREVK EEEEECHHHHCHHHH | 44.53 | 29967540 | |
164 | Phosphorylation | KLADFGLSTFQGGSQ EHHHHCCCEECCCCC | 27.79 | - | |
170 | Phosphorylation | LSTFQGGSQSGTGSG CCEECCCCCCCCCCC | 28.18 | 28348404 | |
172 | Phosphorylation | TFQGGSQSGTGSGEP EECCCCCCCCCCCCC | 39.77 | 28348404 | |
174 | Phosphorylation | QGGSQSGTGSGEPGG CCCCCCCCCCCCCCC | 33.16 | 28348404 | |
176 | Phosphorylation | GSQSGTGSGEPGGTL CCCCCCCCCCCCCCC | 39.56 | 28348404 | |
182 | Phosphorylation | GSGEPGGTLGYLAPE CCCCCCCCCEEECCH | 23.95 | 29883609 | |
199 | Phosphorylation | VNVNRKASTASDVYS EECCCCCCCHHHHHH | 27.78 | 19524512 | |
224 | Phosphorylation | GREVELPTEPSLVYE CCCEECCCCCHHHHH | 73.48 | 26657352 | |
227 | Phosphorylation | VELPTEPSLVYEAVC EECCCCCHHHHHHHH | 25.00 | 26657352 | |
230 | Phosphorylation | PTEPSLVYEAVCNRQ CCCCHHHHHHHHCCC | 11.94 | 28796482 | |
241 | Phosphorylation | CNRQNRPSLAELPQA HCCCCCCCHHHCCCC | 36.65 | 23312004 | |
252 | Phosphorylation | LPQAGPETPGLEGLK CCCCCCCCCCHHHHH | 26.28 | 23312004 | |
267 | Phosphorylation | ELMQLCWSSEPKDRP HHHHHHCCCCCCCCC | 24.67 | 23879269 | |
268 | Phosphorylation | LMQLCWSSEPKDRPS HHHHHCCCCCCCCCC | 33.16 | 23879269 | |
299 | Phosphorylation | NNMNAAVSTVKDFLS HCHHHHHHHHHHHHH | 23.82 | - | |
300 | Phosphorylation | NMNAAVSTVKDFLSQ CHHHHHHHHHHHHHH | 25.61 | - | |
316 | Phosphorylation | RSSNRRFSIPESGQG HHCCCCCCCCCCCCC | 35.11 | 22617229 | |
320 | Phosphorylation | RRFSIPESGQGGTEM CCCCCCCCCCCCCCC | 30.94 | 28450419 | |
325 | Phosphorylation | PESGQGGTEMDGFRR CCCCCCCCCCHHHHH | 34.65 | 29978859 | |
333 | Phosphorylation | EMDGFRRTIENQHSR CCHHHHHHHHHCCCC | 28.52 | 28450419 | |
339 | Phosphorylation | RTIENQHSRNDVMVS HHHHHCCCCCHHHHH | 24.02 | 23401153 | |
359 | Phosphorylation | LNLEEPPSSVPKKCP CCCCCCCCCCCCCCC | 55.47 | 24719451 | |
360 | Phosphorylation | NLEEPPSSVPKKCPS CCCCCCCCCCCCCCC | 48.49 | 28348404 | |
367 | Phosphorylation | SVPKKCPSLTKRSRA CCCCCCCCCCHHHHH | 59.13 | 26657352 | |
372 | Phosphorylation | CPSLTKRSRAQEEQV CCCCCHHHHHCHHHC | 33.26 | - | |
389 | Phosphorylation | AWTAGTSSDSMAQPP HHHCCCCCCCCCCCC | 33.28 | 21601212 | |
401 | Phosphorylation | QPPQTPETSTFRNQM CCCCCCCCCCCCCCC | 33.98 | - | |
410 | Phosphorylation | TFRNQMPSPTSTGTP CCCCCCCCCCCCCCC | 35.15 | 23401153 | |
412 | Phosphorylation | RNQMPSPTSTGTPSP CCCCCCCCCCCCCCC | 43.17 | 26657352 | |
413 | Phosphorylation | NQMPSPTSTGTPSPG CCCCCCCCCCCCCCC | 28.37 | 28450419 | |
414 | Phosphorylation | QMPSPTSTGTPSPGP CCCCCCCCCCCCCCC | 47.77 | 28450419 | |
416 | Phosphorylation | PSPTSTGTPSPGPRG CCCCCCCCCCCCCCC | 22.23 | 28450419 | |
418 | Phosphorylation | PTSTGTPSPGPRGNQ CCCCCCCCCCCCCCC | 42.18 | 30624053 | |
467 | O-linked_Glycosylation | VGDNNYLTMQQTTAL ECCCCEEEEEEECCC | 11.54 | 30770249 | |
486 | Methylation | LAPSGKGRGLQHPPP CCCCCCCCCCCCCCC | 46.24 | 115389587 | |
496 | Phosphorylation | QHPPPVGSQEGPKDP CCCCCCCCCCCCCCH | 25.87 | 28450419 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
182 | T | Phosphorylation | Kinase | RIPK3 | Q9Y572 | PSP |
199 | S | Phosphorylation | Kinase | RIPK3 | Q9Y572 | GPS |
227 | S | Phosphorylation | Kinase | RIPK3 | Q9Y572 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | BIRC2 | Q13490 | PMID:21931591 |
- | K | Ubiquitination | E3 ubiquitin ligase | BIRC3 | Q13489 | PMID:21931591 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RIPK3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RIPK1_HUMAN | RIPK1 | physical | 10339433 | |
TCAM1_HUMAN | TICAM1 | physical | 15064760 | |
TNR1A_HUMAN | TNFRSF1A | physical | 10339433 | |
CTND1_HUMAN | CTNND1 | physical | 21903422 | |
CDC37_HUMAN | CDC37 | physical | 21903422 | |
FKBP4_HUMAN | FKBP4 | physical | 21903422 | |
FKBP5_HUMAN | FKBP5 | physical | 21903422 | |
INP5K_HUMAN | INPP5K | physical | 21903422 | |
PYGL_HUMAN | PYGL | physical | 21903422 | |
RIPK1_HUMAN | RIPK1 | physical | 21903422 | |
STIP1_HUMAN | STIP1 | physical | 21903422 | |
RIPK1_HUMAN | RIPK1 | physical | 22864571 | |
FADD_HUMAN | FADD | physical | 22864571 | |
EPHA4_HUMAN | EPHA4 | physical | 26186194 | |
ZG16B_HUMAN | ZG16B | physical | 26186194 | |
PTPRK_HUMAN | PTPRK | physical | 26186194 | |
DAXX_HUMAN | DAXX | physical | 23260419 | |
RIPK1_HUMAN | RIPK1 | physical | 25882049 | |
RIPK1_HUMAN | RIPK1 | physical | 24098568 | |
RIPK1_HUMAN | RIPK1 | physical | 26786097 | |
FADD_HUMAN | FADD | physical | 26786097 | |
RIPK3_HUMAN | RIPK3 | physical | 27045108 | |
EPHA4_HUMAN | EPHA4 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Receptor interacting protein kinase-3 determines cellular necroticresponse to TNF-alpha."; He S., Wang L., Miao L., Wang T., Du F., Zhao L., Wang X.; Cell 137:1100-1111(2009). Cited for: FUNCTION, PHOSPHORYLATION AT SER-199, AND INTERACTION WITH RIPK1. | |
"Identification of a novel homotypic interaction motif required forthe phosphorylation of receptor-interacting protein (RIP) by RIP3."; Sun X., Yin J., Starovasnik M.A., Fairbrother W.J., Dixit V.M.; J. Biol. Chem. 277:9505-9511(2002). Cited for: RIP HOMOTYPIC INTERACTION MOTIF, PHOSPHORYLATION AT SER-199, ANDINTERACTION WITH RIPK1. |